194 related articles for article (PubMed ID: 20447505)
1. Fibroblast-based cell therapy strategy for recessive dystrophic epidermolysis bullosa.
Yan WF; Murrell DF
Dermatol Clin; 2010 Apr; 28(2):367-70, xii. PubMed ID: 20447505
[TBL] [Abstract][Full Text] [Related]
2. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
[TBL] [Abstract][Full Text] [Related]
3. Cell- and protein-based therapy approaches for epidermolysis bullosa.
Nyström A; Bruckner-Tuderman L; Kern JS
Methods Mol Biol; 2013; 961():425-40. PubMed ID: 23325662
[TBL] [Abstract][Full Text] [Related]
4. Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.
Wong T; Gammon L; Liu L; Mellerio JE; Dopping-Hepenstal PJ; Pacy J; Elia G; Jeffery R; Leigh IM; Navsaria H; McGrath JA
J Invest Dermatol; 2008 Sep; 128(9):2179-89. PubMed ID: 18385758
[TBL] [Abstract][Full Text] [Related]
5. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
[TBL] [Abstract][Full Text] [Related]
6. Strategy for identification of sequence variants in COL7A1 and a novel 2-bp deletion mutation in recessive dystrophic epidermolysis bullosa.
Christiano AM; Hoffman GG; Zhang X; Xu Y; Tamai Y; Greenspan DS; Uitto J
Hum Mutat; 1997; 10(5):408-14. PubMed ID: 9375858
[TBL] [Abstract][Full Text] [Related]
7. Review of collagen VII sequence variants found in Australasian patients with dystrophic epidermolysis bullosa reveals nine novel COL7A1 variants.
Dang N; Klingberg S; Marr P; Murrell DF
J Dermatol Sci; 2007 Jun; 46(3):169-78. PubMed ID: 17425959
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of dystrophic epidermolysis bullosa: mutations in the type VII collagen gene (COL7A1).
Järvikallio A; Pulkkinen L; Uitto J
Hum Mutat; 1997; 10(5):338-47. PubMed ID: 9375848
[TBL] [Abstract][Full Text] [Related]
9. Injection of recombinant human type VII collagen restores collagen function in dystrophic epidermolysis bullosa.
Woodley DT; Keene DR; Atha T; Huang Y; Lipman K; Li W; Chen M
Nat Med; 2004 Jul; 10(7):693-5. PubMed ID: 15195089
[TBL] [Abstract][Full Text] [Related]
10. Cell-based therapy for RDEB: how does it work?
Uitto J
J Invest Dermatol; 2011 Aug; 131(8):1597-9. PubMed ID: 21753764
[TBL] [Abstract][Full Text] [Related]
11. Premature termination codons in the type VII collagen gene (COL7A1) underlie severe, mutilating recessive dystrophic epidermolysis bullosa.
Christiano AM; Anhalt G; Gibbons S; Bauer EA; Uitto J
Genomics; 1994 May; 21(1):160-8. PubMed ID: 8088783
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for recessive dystrophic epidermolysis bullosa.
Titeux M; Pendaries V; Hovnanian A
Dermatol Clin; 2010 Apr; 28(2):361-6, xii. PubMed ID: 20447504
[TBL] [Abstract][Full Text] [Related]
13. Dystrophic epidermolysis bullosa phenotypes in a large consanguineous Tunisian family.
Ouragini H; Cherif F; Kassar S; Floriddia G; Pascucci M; Daoud W; Osman-Dhahri AB; Boubaker S; Castiglia D; Abdelhak S
J Dermatol Sci; 2009 May; 54(2):114-20. PubMed ID: 19261445
[TBL] [Abstract][Full Text] [Related]
14. A phase II randomized vehicle-controlled trial of intradermal allogeneic fibroblasts for recessive dystrophic epidermolysis bullosa.
Venugopal SS; Yan W; Frew JW; Cohn HI; Rhodes LM; Tran K; Melbourne W; Nelson JA; Sturm M; Fogarty J; Marinkovich MP; Igawa S; Ishida-Yamamoto A; Murrell DF
J Am Acad Dermatol; 2013 Dec; 69(6):898-908.e7. PubMed ID: 24075228
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis and characterization of COL7A1 mutations in dystrophic epidermolysis bullosa.
Dang N; Murrell DF
Exp Dermatol; 2008 Jul; 17(7):553-68. PubMed ID: 18558993
[TBL] [Abstract][Full Text] [Related]
16. High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa.
Kühl T; Mezger M; Hausser I; Handgretinger R; Bruckner-Tuderman L; Nyström A
Mol Ther; 2015 Aug; 23(8):1368-1379. PubMed ID: 25858020
[TBL] [Abstract][Full Text] [Related]
17. Normal and gene-corrected dystrophic epidermolysis bullosa fibroblasts alone can produce type VII collagen at the basement membrane zone.
Woodley DT; Krueger GG; Jorgensen CM; Fairley JA; Atha T; Huang Y; Chan L; Keene DR; Chen M
J Invest Dermatol; 2003 Nov; 121(5):1021-8. PubMed ID: 14708601
[TBL] [Abstract][Full Text] [Related]
18. Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo.
Woodley DT; Keene DR; Atha T; Huang Y; Ram R; Kasahara N; Chen M
Mol Ther; 2004 Aug; 10(2):318-26. PubMed ID: 15294178
[TBL] [Abstract][Full Text] [Related]
19. Dystrophic epidermolysis bullosa pruriginosa in Italy: clinical and molecular characterization.
Drera B; Castiglia D; Zoppi N; Gardella R; Tadini G; Floriddia G; De Luca N; Pedicelli C; Barlati S; Zambruno G; Colombi M
Clin Genet; 2006 Oct; 70(4):339-47. PubMed ID: 16965329
[TBL] [Abstract][Full Text] [Related]
20. Dystrophic epidermolysis bullosa pruriginosa is not associated with frequent FLG gene mutations.
Schumann H; Has C; Kohlhase J; Bruckner-Tuderman L
Br J Dermatol; 2008 Aug; 159(2):464-9. PubMed ID: 18565177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]